Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125109742 | 12510974 | 2 | F | 2016 | 20160808 | 20160629 | 20160815 | EXP | BR-PFIZER INC-2016215783 | PFIZER | 55.00 | YR | F | Y | 62.00000 | KG | 20160815 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125109742 | 12510974 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY | M 29709 | 0 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 125109742 | 12510974 | 2 | PS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | U | 20987 | ||||||||||
| 125109742 | 12510974 | 3 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | U | 20987 | ||||||||||
| 125109742 | 12510974 | 4 | SS | PANTOPRAZOLE MAGNESIUM | PANTOPRAZOLE MAGNESIUM | 1 | STRENGTH 40MG | Y | 0 | ||||||||||
| 125109742 | 12510974 | 5 | C | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | STRENGTH 70 MG | 0 | |||||||||||
| 125109742 | 12510974 | 6 | C | NYSTATIN. | NYSTATIN | 1 | UNK | 0 | |||||||||||
| 125109742 | 12510974 | 7 | C | DOMPERIDONE | DOMPERIDONE | 1 | STRENGTH 0.2 MG | 0 | |||||||||||
| 125109742 | 12510974 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 125109742 | 12510974 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125109742 | 12510974 | 1 | Psoriatic arthropathy |
| 125109742 | 12510974 | 5 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125109742 | 12510974 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125109742 | 12510974 | Asthenia | |
| 125109742 | 12510974 | Body temperature increased | |
| 125109742 | 12510974 | Condition aggravated | |
| 125109742 | 12510974 | Depression | |
| 125109742 | 12510974 | Diarrhoea | |
| 125109742 | 12510974 | Fatigue | |
| 125109742 | 12510974 | Fear | |
| 125109742 | 12510974 | Hypotension | |
| 125109742 | 12510974 | Increased bronchial secretion | |
| 125109742 | 12510974 | Loss of consciousness | |
| 125109742 | 12510974 | Musculoskeletal chest pain | |
| 125109742 | 12510974 | Oropharyngeal pain | |
| 125109742 | 12510974 | Rhinitis | |
| 125109742 | 12510974 | Sinusitis | |
| 125109742 | 12510974 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125109742 | 12510974 | 1 | 20160324 | 0 | ||
| 125109742 | 12510974 | 2 | 20160409 | 0 | ||
| 125109742 | 12510974 | 3 | 2016 | 0 | ||
| 125109742 | 12510974 | 4 | 20160324 | 20160409 | 0 | |
| 125109742 | 12510974 | 5 | 2009 | 0 |